Down Syndrome Lithium Trial (DownsLit) v1.1
Research type
Research Study
Full title
Genetically determined brain abnormalities in Down syndrome – towards a treatment : A single blind placebo controlled trial of lithium carbonate in Down Syndrome
IRAS ID
11900
Contact name
Giles Tan
Sponsor organisation
King's College London (IOP)
Eudract number
2008-008342-20
ISRCTN Number
N/A
Research summary
People with Down Syndrome have a learning disability (mental retardation), and eventually develop the pathology of Alzheimer??s Disease in their brains. The reason for this devastating Ó?double hit? is unknown. However, we recently found that a brain chemical called myo-inositol is significantly increased in non-demented Down Syndrome adults, and explains a significant proportion of their learning disability. Myo-inositol also causes the pathology of Alzheimer??s disease in both animal, and test tube, models. We recently found that dementia in Down Syndrome was associated with an increase in myo-inositol compared with Alzheimer's Disease in the general population and also with further increases in myo-inositol compared with Down Syndrome without dementia. Therefore, elevated myo-inositol may thus also be a pathological Ó?tipping point? into early dementia in Down Syndrome. Previous studies of lithium, a medicine that has long been used to treat mood disorders and challenging behaviours, have shown that it reduces myo-inositol in the brain. However, these studies were done in the general population and not in people with Down Syndrome. Hence, we need to know if myo-inositol can be reduced in the brains of people with Down Syndrome. We will do this using a non-invasive brain imaging technique called magnetic resonance spectroscopy to measure myo-inositol in the brains of people with Down Syndrome following a brief treatment with lithium. If successful, this work will form the basis of future treatment trials to both improve cognitive function and reduce the risk for developing Alzheimer??s disease in Down Syndrome.
REC name
London - South East Research Ethics Committee
REC reference
09/H1102/3
Date of REC Opinion
23 Feb 2009
REC opinion
Further Information Favourable Opinion